KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of JSPR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Jasper Therapeutics, Inc.
(Updated on Apr 26, 2024)

Sell candidate since Apr 15, 2024 Loss -22.43% PDF

The Jasper Therapeutics, Inc. stock price fell by -3.68% on the last day (Friday, 26th Apr 2024) from $21.18 to $20.40. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 7.00% from a day low at $20.15 to a day high of $21.56. The price has fallen in 9 of the last 10 days and is down by -26.41% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -20 thousand shares and in total, 52 thousand shares were bought and sold for approximately $1.06 million.

Given the current short-term trend, the stock is expected to rise 64.24% during the next 3 months and, with a 90% probability hold a price between $33.51 and $54.05 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

JSPR Signals & Forecast

There are few to no technical positive signals at the moment. The Jasper Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $21.86 and $26.22. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 08, 2024, and so far it has fallen -32.00%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Jasper Therapeutics, Inc. stock

Jasper Therapeutics, Inc. finds support from accumulated volume at $20.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $1.41 between high and low, or 7.00%. For the last week the stock has had daily average volatility of 7.84%.

Jasper Therapeutics, Inc. is oversold on RSI14 (15). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (JSPR) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Jasper Therapeutics, Inc. to open at $20.70, and during the day (based on 14 day Average True Range), to move between $18.49 and $22.31, which gives a possible trading interval of +/-$1.91 (+/-9.38%) up or down from last closing price. If Jasper Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 18.76% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $20.24 (0.78%) than the resistance at $20.80 (1.96%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Jasper Therapeutics, Inc. stock A Buy?

The Jasper Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Jasper Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.104 Sell Candidate Unchanged

Predicted Opening Price for Jasper Therapeutics, Inc. of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$20.70 ( 1.49%) $20.40

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for JSPR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 22.11 8.40 %
R2 21.57 5.76 %
R1 21.24 4.13 %
Current price: 20.40
Support S1 20.16 -1.15 %
S2 19.83 -2.78 %
S3 19.29 -5.42 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 25.08 22.94 %
R2 24.86 21.86 %
R1 20.80 1.96 %
Current price 20.40
Support S1 20.24 -0.784%
S2 17.50 -14.22%
S3 17.36 -14.90%

FAQ

What is the symbol for Jasper Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Jasper Therapeutics, Inc. is JSPR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Jasper Therapeutics, Inc. Stock?
The Jasper Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Jasper Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Jasper Therapeutics, Inc. Stock?
Jasper Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Jasper Therapeutics, Inc. Stock.

What's the current price of Jasper Therapeutics, Inc. Stock?
As of the end of day on the Apr 26, 2024, the price of an Jasper Therapeutics, Inc. (JSPR) share was $20.40.

What is the 52-week high and low for Jasper Therapeutics, Inc. Stock?
The 52-week high for Jasper Therapeutics, Inc. Stock is $31.01 and the 52-week low is $4.00.

What is the market capitalization of Jasper Therapeutics, Inc. Stock?
As of the Apr 26, 2024, the market capitalization of Jasper Therapeutics, Inc. is 319.513M.

When is the next earnings date for Jasper Therapeutics, Inc.?
The upcoming earnings date for Jasper Therapeutics, Inc. is May 10, 2024.
Click to get the best stock tips daily for free!

About Jasper Therapeutics, Inc.

Jasper Therapeutics. Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The co... JSPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT